Cyclacel Pharmaceuticals to Release Third Quarter 2019 Financial Results

NEXT STORY
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
PREV STORY
Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gluconite Reviews – Alarming Customer Complaints or Fake Hidden Dangers?

author_avatar
NASDAQ Market News

National Burden of Macrolide-Resistant Streptococcus Pneumoniae in the United States From Blood and Respiratory Tract Cultures Approaches 40 Percent

author_avatar
NASDAQ Market News

Oncology Venture AS buyes 5% points Dovitinib ownership from Sass & Larsen and prolong buy back option on 30%

Press releaseSeptember 3, 2018 Oncology Venture AS buys 5% points Dovitinib ownership from Sass ...

author_avatar
NASDAQ Market News